The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization. (https://bit.ly/38G3Zup)Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines.
Gilead begins testing inhalable form of remdisivir for coronavirus
By REUTERS
04/25/2024 09:15 AM
By REUTERS
04/25/2024 09:00 AM
By REUTERS
04/25/2024 07:18 AM
By WALLA!
04/25/2024 02:34 AM
By WALLA!
04/25/2024 02:07 AM
By REUTERS
04/25/2024 01:42 AM
By REUTERS
04/24/2024 08:50 PM